HIV-1 Infection Impairs Dendritic Cell Activation of Natural Killer Cells
Author Information
Author(s): Benlahrech Adel, Gotch Frances, Kelleher Peter, Patterson Steven, Lichterfeld Mathias
Primary Institution: Imperial College London, Chelsea and Westminster Hospital, London, United Kingdom
Hypothesis
How does HIV-1 infection affect the ability of dendritic cells to activate natural killer cells?
Conclusion
HIV-1 infection selectively impairs the ability of plasmacytoid and monocyte-derived dendritic cells to activate natural killer cells.
Supporting Evidence
- Plasmacytoid dendritic cells from HIV-1 patients showed reduced ability to activate natural killer cells.
- Monocyte-derived dendritic cells also exhibited impaired function in stimulating NK cells in HIV-1 infected individuals.
- HAART treatment did not restore the functional capacity of dendritic cells to activate NK cells.
Takeaway
HIV makes it harder for certain immune cells to work together, which can make it tougher for the body to fight the virus.
Methodology
The study involved co-culturing dendritic cells from HIV-1 infected patients with natural killer cells to assess activation markers and cytokine production.
Potential Biases
Potential bias in patient selection and the use of allogeneic NK cells may affect the generalizability of the results.
Limitations
The study's findings may not fully represent all HIV-1 infected individuals due to the specific patient cohort used.
Participant Demographics
The study included 13 treatment-naïve and 12 HAART-treated HIV-1 infected individuals, along with 12 healthy controls.
Statistical Information
P-Value
p=0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website